Accessibility List
Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal has submitted to BSE the Shareholding Pattern f...

16-Apr-2026|3:30PM

As of March 2026, 68.85% is owned by Indian Promoters and 31.15% by Public.

Hikal - Retirement

14-Apr-2026|3:27PM

Hikal Limited has informed the Exchange about Retirement

Hikal - Announcement under Regulation 30 (LODR)-Retir...

14-Apr-2026|3:16PM

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015- Superannua

Hikal - Reply to Clarification- Financial results

13-Apr-2026|4:34PM

The Exchange had sought clarification from Hikal Limited for the quarter en

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug89.30253.20
Aarti Drug364.153,323.60
Aarti Pharma720.856,535.06
Abbott India27,410.0058,244.34
Accent Micro459.051,101.22
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
ICICI P..58.830.93
Tata Sm..48.540.50
Motilal..0.020.04
Bandhan..0.010.04
Motilal..0.000.00
More

Board Meetings

DatePurpose
11/02/2026Quarterly Results &..
13/11/2025Quarterly Results
07/08/2025Quarterly Results
14/05/2025Audited Results & F..
04/02/2025Quarterly Results &..
More